Ratings
0
Nobody has rated this yet. Be the first!
Works
11
Genome remodelling in a basal-like breast cancer metastasis and xenograft
Proteogenomic integration reveals therapeutic targets in breast cancer xenografts
Author Correction: The prognostic effects of somatic mutations in ER-positive breast cancer
PAM50 gene signatures and breast cancer prognosis with adjuvant anthracycline- and taxane-based chemotherapy: correlative analysis of C9741 (Alliance).
Quality Assessments of Long-Term Quantitative Proteomic Analysis of Breast Cancer Xenograft Tissues.
Estrogen receptor expression is high but is of lower intensity in tubular carcinoma than in well-differentiated invasive ductal carcinoma.
Proteogenomics connects somatic mutations to signalling in breast cancer
Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels
Research-based PAM50 signature and long-term breast cancer survival
Reproducible workflow for multiplexed deep-scale proteome and phosphoproteome analysis of tumor tissues by liquid chromatography-mass spectrometry
